Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-07 Purchase | 2026-08-11 5:53 pm | Braveheart Bio Inc. | BRVE | AH Bio Fund IV L.P. AH Equity Partners Bio IV L.L.C. Andreessen Marc L HOROWITZ BENJAMIN A 10% Owner | 1,100,000 | $18 | $19,800,000 | 10,232,420 (Indirect) | View |
| 2026-08-07 Purchase | 2026-08-11 5:31 pm | Braveheart Bio Inc. | BRVE | Chimovits Erez Director 10% Owner | 1,940,000 | $18 | $34,920,000 | 273,333 (Indirect) | View |
| 2026-08-07 Purchase | 2026-08-11 5:27 pm | Braveheart Bio Inc. | BRVE | ORBIMED ADVISORS LLC OrbiMed Capital GP IX LLC OrbiMed Genesis GP LLC Director 10% Owner | 1,940,000 | $18 | $34,920,000 | 273,333 (Indirect) | View |
| 2026-08-07 Purchase | 2026-08-07 5:25 pm | Braveheart Bio Inc. | BRVE | Forbion Growth Opportunities Fund III Cooperatief U.A. Forbion Growth III Management B.V. Forbion Ventures Fund VII Cooperatief U.A. Forbion Ventures VII Management B.V. 10% Owner | 3,600,000 | $18 | $64,800,000 | 21,826,024 (Indirect Direct) | View |
| 2026-08-07 Purchase | 2026-08-07 4:41 pm | Braveheart Bio Inc. | BRVE | Rickey James Paul Chief Financial Officer | 27,777 | $18 | $499,986 | 1,003,575 (Indirect Direct) | View |
| 2026-08-07 Purchase | 2026-08-07 4:31 pm | Braveheart Bio Inc. | BRVE | Viehbacher Christopher Director | 83,333 | $18 | $1,499,994 | 789,857 (Indirect Direct) | View |
| 2026-08-07 Purchase | 2026-08-07 4:31 pm | Braveheart Bio Inc. | BRVE | Malek David I Director | 4,166 | $18 | $74,988 | 1,043,297 (Indirect Direct) | View |
| 2026-08-07 Purchase | 2026-08-07 4:30 pm | Braveheart Bio Inc. | BRVE | Anderson Michele A. Chief Development Officer | 1,111 | $18 | $19,998 | 632,161 (Direct) | View |
| 2026-08-07 Purchase | 2026-08-07 4:30 pm | Braveheart Bio Inc. | BRVE | Murdoch Travis CEO and President | 83,333 | $18 | $1,499,994 | 8,883,637 (Indirect Direct) | View |
| 2026-08-07 Purchase | 2026-08-07 4:30 pm | Braveheart Bio Inc. | BRVE | Lubner David Charles Director | 55,555 | $18 | $999,990 | 115,555 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-08-14 5:00 pm | N/A N/A | Braveheart Bio Inc. | BRVE | Agarwala Vineeta Director | 0 | $0 | 10,232,420 (Indirect) | View |
| 2026-08-07 Conversion | 2026-08-11 5:53 pm | N/A N/A | Braveheart Bio Inc. | BRVE | AH Bio Fund IV L.P. AH Equity Partners Bio IV L.L.C. Andreessen Marc L HOROWITZ BENJAMIN A 10% Owner | 49,132,420 | $0 | 10,232,420 (Indirect) | View |
| 2026-08-07 Conversion | 2026-08-11 5:31 pm | N/A N/A | Braveheart Bio Inc. | BRVE | Chimovits Erez Director 10% Owner | 49,132,420 | $0 | 273,333 (Indirect) | View |
| 2026-08-07 Conversion | 2026-08-11 5:27 pm | N/A N/A | Braveheart Bio Inc. | BRVE | ORBIMED ADVISORS LLC OrbiMed Capital GP IX LLC OrbiMed Genesis GP LLC Director 10% Owner | 49,132,420 | $0 | 273,333 (Indirect) | View |
| 2026-08-07 Conversion | 2026-08-10 10:03 am | N/A N/A | Braveheart Bio Inc. | BRVE | Jiangsu Hengrui Pharmaceuticals Co. Ltd. 10% Owner | 39,920,091 | $0 | 7,420,091 (Direct) | View |
| 2026-08-07 Conversion | 2026-08-07 5:25 pm | N/A N/A | Braveheart Bio Inc. | BRVE | Forbion Growth Opportunities Fund III Cooperatief U.A. Forbion Growth III Management B.V. Forbion Ventures Fund VII Cooperatief U.A. Forbion Ventures VII Management B.V. 10% Owner | 92,123,287 | $0 | 21,826,024 (Direct) | View |
| 2026-08-05 Option Award | 2026-08-07 4:41 pm | N/A 2036-08-04 | Braveheart Bio Inc. | BRVE | Rickey James Paul Chief Financial Officer | 300,000 | $0 | 1,003,575 (Direct) | View |
| 2026-08-05 Option Award | 2026-08-07 4:41 pm | N/A 2036-08-04 | Braveheart Bio Inc. | BRVE | Lohoff Tim Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2026-08-05 Option Award | 2026-08-07 4:31 pm | N/A 2036-08-04 | Braveheart Bio Inc. | BRVE | Chimovits Erez Director 10% Owner | 30,000 | $0 | 30,000 (Direct) | View |
| 2026-08-05 Option Award | 2026-08-07 4:31 pm | N/A 2036-08-04 | Braveheart Bio Inc. | BRVE | Viehbacher Christopher Director | 30,000 | $0 | 789,857 (Direct) | View |
| 2026-08-05 Option Award | 2026-08-07 4:31 pm | N/A 2036-08-04 | Braveheart Bio Inc. | BRVE | Malek David I Director | 30,000 | $0 | 1,043,297 (Direct) | View |
| 2026-08-05 Option Award | 2026-08-07 4:30 pm | N/A 2036-08-04 | Braveheart Bio Inc. | BRVE | Anderson Michele A. Chief Development Officer | 300,000 | $0 | 632,161 (Direct) | View |
| 2026-08-05 Option Award | 2026-08-07 4:30 pm | N/A 2031-08-04 | Braveheart Bio Inc. | BRVE | Murdoch Travis CEO and President | 550,000 | $0 | 8,883,637 (Direct) | View |
| 2026-08-05 Option Award | 2026-08-07 4:30 pm | N/A 2036-08-04 | Braveheart Bio Inc. | BRVE | Bos Jasper Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2026-08-05 Option Award | 2026-08-07 4:30 pm | N/A 2036-08-04 | Braveheart Bio Inc. | BRVE | Lubner David Charles Director | 60,000 | $0 | 115,555 (Direct) | View |
Ownership | 2026-08-06 06:02 am | N/A N/A | Braveheart Bio Inc. | BRVE | Jiangsu Hengrui Pharmaceuticals Co. Ltd. 10% Owner | 0 | $0 | 7,420,091 (Direct) | View |
Ownership | 2026-08-05 9:18 pm | N/A N/A | Braveheart Bio Inc. | BRVE | ORBIMED ADVISORS LLC OrbiMed Capital GP IX LLC Director 10% Owner | 0 | $0 | 10,235,159 (Indirect) | View |
Ownership | 2026-08-05 9:17 pm | N/A N/A | Braveheart Bio Inc. | BRVE | AH Bio Fund IV L.P. AH Equity Partners Bio IV L.L.C. Andreessen Marc L HOROWITZ BENJAMIN A 10% Owner | 0 | $0 | 9,132,420 (Indirect) | View |
Ownership | 2026-08-05 9:13 pm | N/A N/A | Braveheart Bio Inc. | BRVE | Forbion Growth Opportunities Fund III Cooperatief U.A. Forbion Growth III Management B.V. Forbion Ventures Fund VII Cooperatief U.A. Forbion Ventures VII Management B.V. 10% Owner | 0 | $0 | 18,226,024 (Direct) | View |
Ownership | 2026-08-05 9:08 pm | N/A N/A | Braveheart Bio Inc. | BRVE | Rickey James Paul Chief Financial Officer | 0 | $0 | 675,798 (Indirect) | View |
Ownership | 2026-08-05 9:08 pm | N/A N/A | Braveheart Bio Inc. | BRVE | Viehbacher Christopher Director | 0 | $0 | 676,524 (Indirect) | View |
Ownership | 2026-08-05 9:07 pm | N/A N/A | Braveheart Bio Inc. | BRVE | Anderson Michele A. Chief Development Officer | 0 | $0 | 401,826 (Direct) | View |
Ownership | 2026-08-05 9:07 pm | N/A N/A | Braveheart Bio Inc. | BRVE | Chimovits Erez Director 10% Owner | 0 | $0 | 10,235,159 (Indirect) | View |
Ownership | 2026-08-05 9:07 pm | N/A N/A | Braveheart Bio Inc. | BRVE | Murdoch Travis CEO and President 10% Owner | 0 | $0 | 8,250,304 (Indirect) | View |
Ownership | 2026-08-05 9:07 pm | N/A N/A | Braveheart Bio Inc. | BRVE | Malek David I Director | 0 | $0 | 1,009,131 (Indirect) | View |
Ownership | 2026-08-05 9:07 pm | N/A N/A | Braveheart Bio Inc. | BRVE | Coloma Jason V Director | 0 | $0 | 1,100,456 (Indirect) | View |